What is the distinguishing receptor action between typical and atypical antipsychotics?

• A. Typical antipsychotics block D2 and D3; atypicals block D1 only.
• B. Typical antipsychotics block D1 receptors; atypicals block D2 receptors.
• C. Typical antipsychotics have no receptor effects; atypicals block all receptors.
• D. Typical antipsychotics primarily block D2 receptors; atypical antipsychotics block D2 and D3 and other receptors.

Answer: (D)

Understanding how these drugs interact with brain receptors helps explain their different profiles. Both typical and atypical antipsychotics block dopamine D2 receptors to help reduce psychotic symptoms, but their overall receptor binding patterns differ. Typical antipsychotics are mainly D2 antagonists with limited action on other receptors, which contributes to a higher risk of motor side effects known as extrapyramidal symptoms. Atypical antipsychotics, while also blocking D2, have broader activity—they block D2 and D3 receptors and engage other receptors, especially the serotonin 5-HT2A receptors, along with varying effects on histamine, adrenergic, and muscarinic receptors. This broader profile modulates dopamine release in multiple pathways, lowering EPS risk and often improving negative symptoms. So the distinguishing action is that atypical antipsychotics block D2 and D3 and other receptors, whereas typical ones are primarily D2 blockers. The other descriptions don’t fit the pharmacology accurately.